Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registryLutz Buellesfeld
Heart Center Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 66:173-7. 2005
..The quantitative angiographic analysis revealed beneficial results with respect to the efficacy surrogates binary restenosis rate and late loss...
- [Percutaneous aortic valve replacement]
Eberhard Grube
Medizinische Klinik Kardiologie und Angiologie, HELIOS Klinikum Siegburg, Ringstrasse 49, 53721 Siegburg
Herz 31:694-7. 2006
..However, the strict inclusion criteria for both procedures limit the number of potential candidates. New devices are currently under development, which will allow for a broader use of percutaneous valve replacement in the near future...
- Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients
Carlo Di Mario
Catheterization Laboratory, Royal Brompton Hospital, Sydney Street, London, UK
Catheter Cardiovasc Interv 69:416-24. 2007
..The aim of the study was the assessment of the clinical, angiographic and procedural characteristics correlated with freedom from adverse events at 1 year in a real life setting of consecutive bifurcation lesions...
Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trialMarcus Wiemer
Department of Cardiology, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Catheter Cardiovasc Interv 75:997-1003. 2010
..However, long-term follow-up data are scarce and only available for sirolimus- and paclitaxel-eluting stents...
- The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions
Eberhard Grube
Department of Cardiology, University Hospital Bonn, Bonn, Germany
Am Heart J 163:867-875.e1. 2012
..Our main aim was to evaluate the angiographic efficacy of XIENCE V (everolimus-eluting stent, or EES) in diabetic patients compared with TAXUS Liberté (paclitaxel-eluting stent, or PES)...
- TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
Eberhard Grube
Department of Cardiology Angiology, Heart Center Siegburg, Siegburg, Germany
Circulation 107:38-42. 2003
..The TAXUS I trial was the first in-human experience evaluating safety and feasibility of the TAXUS NIRx stent system compared with bare NIR stents (control) (Boston Scientific Corp) for treatment of coronary lesions...
- Drug eluting stents: initial experiences
E Grube
Heart Center Siegburg Ringstrasse 49 53721 Siegburg, Germany
Z Kardiol 91:44-8. 2002
....
- [Surgical or interventional aortic valve repair? Pro interventional repair]
E Grube
HELIOS Klinikum Siegburg, Medizinische Klinik Kardiologie Angiologie, 53721 Siegburg
Dtsch Med Wochenschr 133:2021. 2008
- TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions
Eberhard Grube
HELIOS Heart Center Siegburg, Siegburg, Germany
Eur Heart J 28:2578-82. 2007
..In order to assess the long-term safety and clinical efficacy of the polymer-based moderate release (MR) paclitaxel-eluting TAXUS MR stent in treatment of complex lesion subsets, we evaluated the 2-year follow-up of TAXUS VI...
- Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome
Eberhard Grube
HELIOS Heart Center Siegburg, Siegburg, Germany
J Am Coll Cardiol 50:69-76. 2007
..We sought to determine both the procedural performance and safety of percutaneous implantation of the second (21-French [F])- and third (18-F)-generation CoreValve aortic valve prosthesis (CoreValve Inc., Irvine, California)...
- Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings
Eberhard Grube
HELIOS Heart Center, Siegburg, Germany
Am J Cardiol 99:1691-7. 2007
..In conclusion, the Axxess Plus conical stent effectively treats bifurcation lesions alone or in conjunction with other drug-eluting stents...
- Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study
Eberhard Grube
Department of Cardiology Angiology, HELIOS Heart Center Siegburg, Ringstrasse 49, 53721 Siegburg, Germany
Circulation 114:1616-24. 2006
....
- High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial
Eberhard Grube
J Am Coll Cardiol 44:1368-72. 2004
..Santa Clara, California/Boston Scientific Corp., Natick, Massachusetts) versus uncoated control stents (n = 140) in focal, de novo coronary lesions...
- Paclitaxel-eluting stents: current clinical experience
Eberhard Grube
Heart Center Siegburg, Siegburg, Germany
Am J Cardiovasc Drugs 4:355-60. 2004
..Programs like these are vital to sufficiently monitor patients who have received a drug-eluting stent, particularly because of the controversy regarding long-term effects...
- BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease
Eberhard Grube
HELIOS Heart Center Siegburg, Department of Cardiology Angiology, Ringstrasse 49, 53721 Siegburg, Germany
Expert Rev Med Devices 3:731-41. 2006
..Clinical studies have demonstrated the BioMatrix to be well tolerated and effective, and it has now become the subject of an aggressive clinical program...
- TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions
Eberhard Grube
HELIOS Heart Center, Department of Cardiology Angiology, Ringstrasse 49, 53721, Siegburg, Germany
EuroIntervention 4:572-7. 2009
..To assess the long-term safety and efficacy of the paclitaxel-eluting TAXUS moderate-release (MR) investigation-only stent for the treatment of long, complex coronary artery lesions...
- Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system
Eberhard Grube
Departments of Cardiology, Cardiac Surgery, and Anaesthesiology, HELIOS Heart Center Siegburg, Ringstrasse 49, Siegburg, Germany
Circ Cardiovasc Interv 1:167-75. 2008
..This study was intended to provide a summary of the development and current safety and efficacy status of the self-expanding CoreValve Revalving prosthesis...
- Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection
E Grube
Department of Cardiology Angiology, Heart Center Siegburg, Siegburg, Germany
Circulation 104:2436-41. 2001
..This report details the first clinical experience of the effectiveness and safety of an emboli protection system in 11 SVG lesions and 15 native coronary artery lesions...
- Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study
Eberhard Grube
Department of Medicine II, University Hospital Bonn, Bonn, Germany
JACC Cardiovasc Interv 4:751-7. 2011
..The purpose of this pilot study was to evaluate the feasibility and safety of transcatheter aortic valve implantation (TAVI) without balloon pre-dilation...
- The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions
Eberhard Grube
Department of Cardiology, University Hospital Bonn, Bonn, Germany
JACC Cardiovasc Interv 4:168-75. 2011
....
- Drug-eluting stents: clinical experiences and perspectives
E Grube
Heart Center Siegburg, Siegburg, Germany, Italy
Minerva Cardioangiol 50:469-73. 2002
..Nevertheless, we need more trials and an agreement of definitions in order to evaluate this treatment concept and eliminate unwanted side-effects...
- Images in cardiovascular medicine. Intracoronary imaging with optical coherence tomography: a new high-resolution technology providing striking visualization in the coronary artery
Eberhard Grube
Department of Cardiology/Angiology, Heart-Center Siegburg, Siegburg, Germany
Circulation 106:2409-10. 2002
- A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent
Eberhard Grube
HELIOS Heart Center, Siegburg, Germany
JACC Cardiovasc Interv 3:431-8. 2010
....
- First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis
Eberhard Grube
Department of Cardiology, Heart Center Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 66:465-9. 2005
..7 cm2). Surgical valve replacement had been declined for the patient because of comorbidities, including previous bypass surgery...
- Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results
Eberhard Grube
Department of Cardiology Angiology, HELIOS Heart Center Siegburg, Siegburg, Germany
EuroIntervention 4:71-6. 2008
....
- Initial experience with paclitaxel-coated stents
Eberhard Grube
Heart Center Siegburg, Ringstrasse 49, 53721 Siegburg, Germany
J Interv Cardiol 15:471-5. 2002
....
- Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer
Eberhard Grube
Heart Center Siegburg, Siegburg, Germany
Circulation 109:2168-71. 2004
..CONCLUSIONS: In this initial clinical experience, EES with bioabsorbable polymer demonstrated a safe and efficacious method to reduce in-stent neointimal hyperplasia and restenosis...
- Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I
L Büllesfeld
Abt für Kardiologie Angiologie, Krankenhaus and Herzzentrum Siegburg, Ringstrasse 49, 53721 Siegburg, Germany
Z Kardiol 92:825-32. 2003
..Therefore, this stent design seems to be safe and effective, even in long-term follow-up...
- Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography
L Buellesfeld
Department of Cardiology Angiology, Heart Center Siegburg, Ringstrasse 49, 53721, Siegburg, Germany
Z Kardiol 94:690-4. 2005
..Compared to IVUS, OCT proved the coverage of the stent struts adjacent to the vessel wall with a superior imaging quality and, in addition, provided new insights into the stent performance at the open bifurcation site...
- Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry
Victor Y Lim
Department of Cardiology and Angiology, HELIOS Heart Center Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 68:343-8. 2006
..1%) at 3 days after intervention. CONCLUSIONS: Paclitaxel-eluting Taxus stent for the treatment of ISR effectively suppresses recurrent neointimal proliferation, and was safe and efficacious at 6-month follow-up...
- Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results
Ulrich Gercken
Department of Cardiology and Angiology, Heart-Center, Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 56:353-60. 2002
..Covered stents such as the JoMed coronary stent graft may become essential for bailout treatment of coronary perforations...
- Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents
Eberhard Grube
Department of Cardiology Angiology, Heart Center Siegburg, Germany
Herz 29:162-6. 2004
....
- Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial
Eberhard Grube
Department of Cardiology and Angiology, Heart Center, Siegburg, Germany
J Invasive Cardiol 18:194-8. 2006
....
- ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?
Lutz Buellesfeld
Department of Cardiology Angiology, Heart Center Siegburg, Germany
Herz 29:167-70. 2004
..If the results of both pivotal studies ENDEAVOR II and III confirm the efficacy of the ENDEAVOR stent design observed so far, the ENDEAVOR stent will be established as a new and promising contender in the field of DES...
- Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis
Lutz Buellesfeld
Department of Cardiology, HELIOS Heart Center Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 71:579-84. 2008
..We implanted this prosthesis in a 93-year old patient presenting with severe symptomatic aortic stenosis (valve area: 0.6 cm(2)). Surgical valve replacement had been declined due to comorbidities...
- Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients
George Latsios
Department of Cardiology and Angiology, Heart Center Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 75:1129-36. 2010
....
- Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system
Peter Wenaweser
Department of Cardiology Angiology, HELIOS Heart Center Siegburg, Siegburg, Germany
Catheter Cardiovasc Interv 70:760-4. 2007
..We report on the first successful valve in valve procedure in an 80-year-old patient with a severe regurgitation of a degenerated aortic bioprosthesis using the Corevalve Revalving system...
- Percutaneous transluminal coronary angioplasty of left main stenosis--results of the German PTCA registry
S Miketic
Medizinische Klinik II Klinikum Lippe Detmold
Z Kardiol 89:508-12. 2000
..The risk stratification of the procedure can be evaluated by the proposed grading of left main artery protection...
- Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardio
R Zahn
Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg Süd, Nurnberg
Heart 94:329-35. 2008
..The formerly observed volume-outcome relation for percutaneous coronary interventions (PCIs) has recently been questioned...
Incidental finding of a papillary fibroelastoma on the aortic valve in 16 slice multi-detector row computed tomographyA Bootsveld
CT MRI Center Siegburg, Germany
Heart 90:e35. 2004
..This report describes the characteristics of a PFE with multidetector 16 slice computed tomography and 1.5 Tesla cardiac magnetic resonance imaging...
- [Brugada syndrome or ARVD (arrhythmogenic right ventricular dysplasia) or both? Significance and value of right precordial ECG changes]
Th Schmidt
Medizinische Klinik Kardiologie Krankenhaus Siegburg Ringstrasse 49 53721 Siegburg, Germany
Z Kardiol 91:416-22. 2002
..As a prognostic indication we decided to implant an ICD prophylactically. The case report demonstrates the value of familiar examination of patients with an unclear ventricular arrhythmogenic event...
- Optical Coherence Tomography (OCT). Potential of a new high-resolution intracoronary imaging technique
Ulrich Gerckens
Department of Cardiology Angiology, Heart Center, Klinikum Siegburg Rhein Sieg GmbH, Siegburg, Germany
Herz 28:496-500. 2003
....
- Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial
L Nelson Hopkins
Department of Neurosurgery, University of Buffalo and Toshiba Stroke Center, Buffalo, New York 14209, USA
Catheter Cardiovasc Interv 71:950-60. 2008
..The multicenter, single-arm CABERNET trial evaluated outcomes in high-surgical-risk patients with carotid artery stenosis treated with the NexStent plus FilterWire EX/EZ Emboli Protection System...
- Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial
L Nelson Hopkins
University at Buffalo, NY, USA
EuroIntervention 5:917-24. 2010
..To investigate long-term outcomes achieved in high-surgical-risk patients and other clinically-relevant subgroups after carotid stenting with the NexStent and Filterwire EX/EZ devices...
- Transcatheter aortic valve implantation: first results from a multi-centre real-world registry
Ralf Zahn
Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
Eur Heart J 32:198-204. 2011
..We report the first results of the prospective multi-centre German Transcatheter Aortic Valve Interventions-Registry...
- Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I)
Eberhard Grube
Heart Center Siegburg, Siegburg, Germany
Am J Cardiol 96:79-82. 2005
..The single target vessel revascularization in the TAXUS group was remote from the target lesion in contrast to 3 target lesion revascularizations in the control group...
- High-frequency mechanical vibration to recanalize chronic total occlusions after failure to cross with conventional guidewires
Eberhard Grube
Klinikum Siegburg, Siegburg, Germany
J Invasive Cardiol 18:85-91. 2006
..CONCLUSIONS: The CROSSER system is a safe device that can cross many occlusions after a conventional guidewire failure. With additional refinement and improvements to the device, this success rate could be further increased...
- Everolimus for stent-based intracoronary applications
Eberhard Grube
Heart-Center Siegburg, Siegburg, Germany
Rev Cardiovasc Med 5:S3-8. 2004
..The everolimus-eluting coronary stent might shortly be established as a new and promising contender in the field of drug eluting stents for treatment of coronary heart disease...
- Computerized two-lead resting ECG analysis for the detection of coronary artery stenosis after coronary revascularization
Eberhard Grube
Department of Cardiology, Angiology, HELIOS Heart Center Siegburg, Siegburg, Germany
Int J Med Sci 5:50-61. 2008
..We compared a new computer-enhanced, resting ECG analysis device, 3DMP, to coronary angiography to evaluate the device's accuracy in detecting hemodynamically relevant CAD...
- [Optical coherence tomography imaging in coronary drug-eluting stenting]
Ulrich Gerckens
Department of Cardiology-Angiology, Heart Center Siegburg, Siegburg, Germany
Rev Esp Cardiol 58:1469. 2005
- Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation
Eberhard Grube
Heart Center, Siegburg, Germany
Catheter Cardiovasc Interv 58:139-46. 2003
....
Computerized two-lead resting ECG analysis for the detection of coronary artery stenosisEberhard Grube
Department of Cardiology, Angiology, Heart Center Siegburg, Klinikum Siegburg, Ringstrasse 49, D 53721 Siegburg, Germany
Int J Med Sci 4:249-63. 2007
..We compared a new computer-enhanced, resting ECG analysis device, 3DMP, to coronary angiography to evaluate the device's accuracy in detecting hemodynamically relevant CAD...
- Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
Antonio Colombo
Ospedale San Raffaele, Milano, Italy
Circulation 108:788-94. 2003
..Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after treatment of de novo coronary lesions in small patient populations...
- Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry
Marco De Carlo
Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
Catheter Cardiovasc Interv 72:196-203. 2008
..The aim of this study was to investigate the safety and efficacy of an innovative thrombectomy device, the Rinspiration System, which simultaneously "rinses" the vessel with turbulent flow and aspirates thrombus...
- Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus
Masashi Kimura
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 101:1263-8. 2008
....
- Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials
Neil J Weissman
Cardiac Ultrasound and Ultrasound Core Laboratory, Cardiovascular Research Institute Medstar Research Institute, Washington Hospital Center, 100 Irving Street, NW, Suite EB 5123, Washington, DC 20010, USA
Eur Heart J 28:1574-82. 2007
..Since intravascular ultrasound (IVUS) methodology and core laboratory were consistent among all three TAXUS trials, an integrated analysis of 956 patients across all IVUS cohorts can be performed providing superior power...
- Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions
Alberto Fonseca
Instituto Dante Pazzanese de Cardiologia, Sao Paulo SP, Brasil
J Invasive Cardiol 20:21-7. 2008
..We sought to investigate the safety, feasibility and mechanism of action of a new scoring-balloon catheter, the AngioSculpt, comprised of a semicompliant balloon and a nitinol spiral cage designed to address complex lesions...
- Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry)
Cosmo Godino
Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy
Am J Cardiol 102:1002-8. 2008
..The rate of subacute and late stent thrombosis was low in this subgroup of patients...
- 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)
Toru Kataoka
Center for Research in Cardiovascular Interventions, Stanford University, Stanford, Calif 94305, USA
Circulation 106:1788-93. 2002
....
- [State of treatment of coronary artery disease by drug releasing stents]
Ralf Muller
Abteilung für Kardologie, Herzzentrum Siegburg, Germany
Herz 27:508-13. 2002
....
- Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction
Simon R Dixon
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
J Am Coll Cardiol 40:1928-34. 2002
..The purpose of this study was to evaluate the safety and feasibility of endovascular cooling during primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
- TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation
Kengo Tanabe
Division of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Circulation 107:559-64. 2003
..CONCLUSIONS: Paclitaxel-eluting stent implantation is considered safe and potentially efficacious in the treatment of ISR. IVUS guidance to ensure good stent deployment with complete coverage of target lesion may reduce reintervention...
- Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients
Michael Haude
Cardiology Clinic, University Essen, Essen, Germany
Circulation 107:1265-70. 2003
..Therefore, we performed this prospective, randomized trial to evaluate the angiographic and clinical outcome after treatment of stenoses in small coronary arteries (2.0 to 2.6 mm) of symptomatic patients...
- Influence of plaque calcium on neointimal hyperplasia following bare metal and drug-eluting stent implantation
Yoshihisa Shimada
The Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
Catheter Cardiovasc Interv 67:866-9. 2006
..0.3 +/- 0.6 mm2, P = NS). CONCLUSIONS: These results suggest that while plaque calcium may influence NIH following BMS implantation, NIH suppression using DES does not appear to be affected by the presence or location of calcium...
- Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data)
Gregg W Stone
The Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 102:1017-22. 2008
....
- Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials)
Jiro Aoki
Columbia University Medical Center, New York, New York, USA
Am J Cardiol 102:1009-16. 2008
..In conclusion, neointimal proliferation was less prominent and expansive vessel remodeling was more prominent after PES than BMS implantation, independent of the severity of renal dysfunction...
- Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study
Sigmund Silber
Internistische Klinik Dr Müller, Herzkatheterlabor Cardiology Associates, Munich, Germany
J Interv Cardiol 16:491-7. 2003
..No other MACE were observed during the three-month follow-up period. Based on the findings of this study, direct stenting with the EXPRESS Stent appears feasible and is well tolerated...
- Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial
Akiyoshi Miyazawa
Stanford University Medical Center, Stanford, CA 94305 5637, USA
Catheter Cardiovasc Interv 70:952-7. 2007
..The aim of this intravascular ultrasound (IVUS) study was to assess the efficacy of the AXXESS Plus stent system for the treatment of bifurcation coronary lesions...
- Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial
Patrick W Serruys
Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 44:1363-7. 2004
..We sought to demonstrate the safety and performance of the actinomycin D-coated Multilink-Tetra stent(Guidant Corp., Santa Clara, California) in the treatment of patients with single de novo native coronary lesions...
- Clinical experiences using everolimus-eluting stents in patients with coronary artery disease
Hans Störger
Red Cross Hospital Cardiology Center, Frankfurt, Germany
J Interv Cardiol 17:387-90. 2004
..0001). In FUTURE II, a randomized multi-center study, a total of 64 patients were enrolled confirming safety and feasibility. After 6 months late loss was 0.85 mm in the control group and 0.12 mm in the everolimus group (p < 0.001)...
- Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)
Yoshihiro Tsuchiya
The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 98:464-9. 2006
..The EES appears to be effective for treatment of de novo coronary lesions in decreasing neointimal proliferation at 6-month follow-up compared with BMSs, regardless of vessel size...
- Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions
Ricardo A Costa
The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 98:443-6. 2006
..14 +/- 0.45 vs 0.40 +/- 0.41 mm, p = 0.004). In-stent restenosis was 3.9% in the Biolimus stent group versus 7.7% in the control group (p = 0.40). There was no exaggerated hyperplasia at the proximal and/or distal edge of the stent...
- Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials
Jeffrey W Moses
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
J Am Coll Cardiol 47:2164-71. 2006
....
- Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement
Franz Josef Neumann
Herz Zentrum Bad Krozingen, Bad Krozingen, Germany
Circulation 111:2107-11. 2005
..This study sought to assess the effectiveness and safety of the sirolimus-eluting stent in the treatment of in-stent restenosis...
- Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study
Giuseppe G L Biondi-Zoccai
Int J Cardiol 108:406-7. 2006
..These findings thus support the overall safety and effectiveness of ticlopidine after DES implantation, and also confirm the increased risk of late thrombosis when premature withdrawal of thienopyridines occurs...
- Acute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter nonrandomized feasibility study
Fumiaki Ikeno
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA
Catheter Cardiovasc Interv 67:198-206. 2006
..CONCLUSION: In this consecutive multicenter series of patients with coronary bifurcation lesions, this novel side-branch access stent proved feasible, with a high procedural success rate, while maintaining side-branch access...
- An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program
John M Lasala
Division of Cardiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Interv Cardiol 19:422-31. 2006
....
- Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial
William Wijns
Cardiovascular Centre, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium
Eur Heart J 26:1852-9. 2005
..The objective was to demonstrate equivalence of post-procedural mean luminal diameter (MLD) by angiography after BeStent2 placement between DS and pre-dilatation (PD) strategy...
- Initial and follow-up results of the European Seaquence coronary stent registry
Martial Hamon
Service des Maladies du Coeur et des Vaisseaux, Avenue Cote de Nacre, CHU de Caen, 14 033 Caen Cedex, France
J Interv Cardiol 17:9-15. 2004
....
- Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial
Alexandre Abizaid
Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
Catheter Cardiovasc Interv 70:654-60. 2007
....
- Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution
Rainer Hoffmann
Medical Clinic I, University Aachen, Aachen, Germany
Am J Cardiol 93:760-2. 2004
..At 6-month follow-up, in-stent late loss was 0.44 +/- 0.54 mm and the restenosis rate was 20%, indicating effective treatment for reduction of recurrent restenosis...
- Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI)
Esteban Escolar
Cardiovascular Research Institute Medstar Research Institute, Washington Hospital Center, Washington, DC, USA
Am J Cardiol 100:621-6. 2007
..91 and p <0.001. In conclusion, the QCA and IVUS parameters used to evaluate drug-eluting stent efficacy showed a moderate correlation with IVUS percentage of intimal hyperplasia, reliably predicting QCA binary in-stent restenosis...
- Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II
Sigmund Silber
Cardiology Practice and Hospital, Munich, Germany
Herz 29:171-80. 2004
..While predilatation was recommended per protocol, direct stenting was not forbidden: thus, direct stenting was performed in 49 patients (TAXUS n = 23, control n = 26)...
- Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy
Peter W Radke
Medical Clinic I, RWTH University Hospital, Pauwelsstrasse 30, 52057 Aachen, Germany
Eur Heart J 25:920-5. 2004
..This matched-pair analysis compared the procedural and long-term clinical and angiographic outcome after treatment of diffuse ISR using a paclitaxel-eluting stent (PES) with intracoronary beta-radiation therapy...
- Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years
Stephen G Ellis
Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, Ohio 44195, USA
J Am Coll Cardiol 49:1043-51. 2007
..This study sought to study stent thrombosis with the paclitaxel-eluting Taxus stent...
- Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 356:998-1008. 2007
..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
- Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice
Keith D Dawkins
Southampton University Hospital, Southampton, UK
Circulation 112:3306-13. 2005
..Intracoronary polymer-based stent delivery of paclitaxel has been shown to be effective in reducing restenosis in simple coronary lesions, but the evidence base for contemporary use in longer, more complex coronary stenoses is lacking...
